Idris Al Abaidani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Idris Al Abaidani has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Seif Al-Abri
Department of Medicine, Royal Hospital, Muscat, Oman
5 shared publications - Amal Al Maani
Center for Disease Control and Prevention, Ministry of Health, Muscat, Oman
3 shared publications - Bader Al-Rawahi
Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
2 shared publications - Doaa M. Abdel-Hady
Mansoura University Hospital
2 shared publications - Hanan Al Kindi
Central Public Health Laboratories, Center for Disease Control and Prevention, Ministry of Health, Muscat 100, Oman
2 shared publications Khalid Al-Mashikhi
Directorate General of Health Services, Dhofar Governorate, Ministry of Health, Salalah, Oman
2 shared publications
Latest Publications
- Open Access
- 31 December 2018
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 8 (3-4) , 231-235
Epidemiology of Meningitis in Oman—Implications for Future Surveillance
Objectives: This study aimed to understand the epidemiology of meningitis cases admitted to hospitals in Oman and to identify any changing microbial patterns from the introduction of the new vaccines. Methods: A retrospective analysis of all cases of meningitis reported through a national surveillance system. Meningitis is a notifiable disease. Results:...
- 31 December 2018
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 8 (3-4) , 231-235
Open AccessEpidemiology of Meningitis in Oman—Implications for Future Surveillance
Objectives: This study aimed to understand the epidemiology of meningitis cases admitted to hospitals in Oman and to identify any changing microbial patterns from the introduction of the new vaccines. Methods: A retrospective analysis of all cases of meningitis reported through a national surveillance system. Meningitis is a notifiable disease. Results:...
- Open Access
Molecular epidemiology and high mortality of Crimean-Congo hemorrhagic fever in Oman: a re-emerging infection
Background Crimean-Congo hemorrhagic fever (CCHF) is a serious disease with a high fatality rate reported in many countries. The first case of CCHF in Oman was detected in 1995 and serosurveys have suggested widespread infection of humans and livestock throughout the country. Methodology Cases of CCHF reported to the Ministry of Health (MoH) of Oman between 1995 and 2017 were retrospectively reviewed. Diagnosis was confirmed by serology and/or molecular tests in Oman. Stored RNA from recent cases was studied by sequencing the complete open reading frame (ORF) of the viral S segment at Public Health England, enabling phylogenetic comparisons to be made with other S segments of strains obtained from the region. Findings Of 88 cases of CCHF, 4 were sporadic in 1995 and 1996, then none occurred until 2011. From 2011-2017, incidence has steadily increased and 19 (23.8%) of 80 cases clustered around Eid Al Adha. The median (range) age was 33 (15-68) years and 79 (90%) were male. The major risk for infection was contact with animals and/or butchering in 73/88 (83%) and only one case was related to tick bites alone. Severe cases were over-represented: 64 (72.7%) had a platelet count < 50 x 109/L and 32 (36.4%) died. There was no intrafamilial spread or healthcare-associated infection. The viral S segments from 11 patients presenting in 2013 and 2014 were all grouped in Asia 1 (IV) lineage. Conclusions CCHF is well-established throughout Oman, with a single strain of virus present for at least 20 years. Most patients are men involved in animal husbandry and butchery. The high mortality suggests that there is substantial under-diagnosis of milder cases. Preventive measures have been introduced to reduce risks of transmission to animal handlers and butchers and to maintain safety in healthcare settings.
Open AccessMolecular epidemiology and high mortality of Crimean-Congo hemorrhagic fever in Oman: a re-emerging infection
Background Crimean-Congo hemorrhagic fever (CCHF) is a serious disease with a high fatality rate reported in many countries. The first case of CCHF in Oman was detected in 1995 and serosurveys have suggested widespread infection of humans and livestock throughout the country. Methodology Cases of CCHF reported to the Ministry of Health (MoH) of Oman between 1995 and 2017 were retrospectively reviewed. Diagnosis was confirmed by serology and/or molecular tests in Oman. Stored RNA from recent cases was studied by sequencing the complete open reading frame (ORF) of the viral S segment at Public Health England, enabling phylogenetic comparisons to be made with other S segments of strains obtained from the region. Findings Of 88 cases of CCHF, 4 were sporadic in 1995 and 1996, then none occurred until 2011. From 2011-2017, incidence has steadily increased and 19 (23.8%) of 80 cases clustered around Eid Al Adha. The median (range) age was 33 (15-68) years and 79 (90%) were male. The major risk for infection was contact with animals and/or butchering in 73/88 (83%) and only one case was related to tick bites alone. Severe cases were over-represented: 64 (72.7%) had a platelet count < 50 x 109/L and 32 (36.4%) died. There was no intrafamilial spread or healthcare-associated infection. The viral S segments from 11 patients presenting in 2013 and 2014 were all grouped in Asia 1 (IV) lineage. Conclusions CCHF is well-established throughout Oman, with a single strain of virus present for at least 20 years. Most patients are men involved in animal husbandry and butchery. The high mortality suggests that there is substantial under-diagnosis of milder cases. Preventive measures have been introduced to reduce risks of transmission to animal handlers and butchers and to maintain safety in healthcare settings.
- Open Access
- 1 September 2018
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 11 (5) , 742-744
Effective vaccine management and Oman’s healthcare system’s challenge to maintain high global standards
- 1 September 2018
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 11 (5) , 742-744
Open AccessEffective vaccine management and Oman’s healthcare system’s challenge to maintain high global standards
- Open Access
- 12 December 2016
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 5 (1) , 112
Decline in transmission of schistosomiasis mansoni in Oman
Intestinal schistosomiasis due to Schistosoma mansoni was first reported in Oman in 1979. We describe the trend in parasitological and serological prevalence of human infection with S. mansoni in the endemic area over the period 1982–2014, and the compliance of data generated by the national monitoring and evaluation system with schistosomiasis elimination criteria set by the Ministry of Health of Oman. Parasitological and serological assessments were carried out on population (mainly children) living in the area at risk for schistosomiasis in Dhofar, the country’s only endemic Governorate, for a period of over 30 years. Kato-Katz thick smear and Indirect Haemagglutination Assay were the techniques employed. Data indicate a progressive decline in prevalence of S. mansoni throughout the 1980s and the 1990s, a recrudescence in the early 2000s, and a more marked decrease following the implementation of six rounds of mass treatment with praziquantel from 2007 to 2013. Latest parasitological prevalence (2011) was 0%, while latest serological prevalence (2014) was 0.11%. Transmission of schistosomiasis has reached very low levels in Oman. Elimination criteria established by the Ministry of Health of Oman (parasitological prevalence ≤ 1% and serological prevalence ≤ 5%) have been met since 2008. Further investigations are required to assess whether interruption of transmission has been achieved in some or all foci, in view of the establishment of a formal verification process under the auspices of WHO.
- 12 December 2016
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 5 (1) , 112
Open AccessDecline in transmission of schistosomiasis mansoni in Oman
Intestinal schistosomiasis due to Schistosoma mansoni was first reported in Oman in 1979. We describe the trend in parasitological and serological prevalence of human infection with S. mansoni in the endemic area over the period 1982–2014, and the compliance of data generated by the national monitoring and evaluation system with schistosomiasis elimination criteria set by the Ministry of Health of Oman. Parasitological and serological assessments were carried out on population (mainly children) living in the area at risk for schistosomiasis in Dhofar, the country’s only endemic Governorate, for a period of over 30 years. Kato-Katz thick smear and Indirect Haemagglutination Assay were the techniques employed. Data indicate a progressive decline in prevalence of S. mansoni throughout the 1980s and the 1990s, a recrudescence in the early 2000s, and a more marked decrease following the implementation of six rounds of mass treatment with praziquantel from 2007 to 2013. Latest parasitological prevalence (2011) was 0%, while latest serological prevalence (2014) was 0.11%. Transmission of schistosomiasis has reached very low levels in Oman. Elimination criteria established by the Ministry of Health of Oman (parasitological prevalence ≤ 1% and serological prevalence ≤ 5%) have been met since 2008. Further investigations are required to assess whether interruption of transmission has been achieved in some or all foci, in view of the establishment of a formal verification process under the auspices of WHO.
- 17 February 2016
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 9 (2) , 200-202
Ebola preparedness in Oman: An experience from the Middle East
- 17 February 2016
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 9 (2) , 200-202
Ebola preparedness in Oman: An experience from the Middle East
- Open Access
- 1 January 2016
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 6 (4) , 215-216
Four cases of nontravel-related leptospirosis in Oman: A call for action
- 1 January 2016
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 6 (4) , 215-216
Open AccessFour cases of nontravel-related leptospirosis in Oman: A call for action
- 1 September 2015
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 13 (5) , 388-393
Epidemiology of travel-associated infections in Oman 1999–2013: A retrospective analysis
- 1 September 2015
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 13 (5) , 388-393
Epidemiology of travel-associated infections in Oman 1999–2013: A retrospective analysis
- Open Access
- 1 December 2014
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 29, 309-310
Overview of preparedness and response for Middle East respiratory syndrome coronavirus (MERS-CoV) in Oman
- 1 December 2014
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 29, 309-310
Open AccessOverview of preparedness and response for Middle East respiratory syndrome coronavirus (MERS-CoV) in Oman
- Open Access
- 17 June 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 334
Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Rotavirus gastroenteritis (RGE) is the leading cause of diarrhea in young children in Oman, incurring substantial healthcare and economic burden. We propose to formally assess the potential cost effectiveness of implementing universal vaccination with a pentavalent rotavirus vaccine (RV5) on reducing the health care burden and costs associated with rotavirus gastroenteritis (RGE) in Oman
- 17 June 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 334
Open AccessCost effectiveness of a pentavalent rotavirus vaccine in Oman
Rotavirus gastroenteritis (RGE) is the leading cause of diarrhea in young children in Oman, incurring substantial healthcare and economic burden. We propose to formally assess the potential cost effectiveness of implementing universal vaccination with a pentavalent rotavirus vaccine (RV5) on reducing the health care burden and costs associated with rotavirus gastroenteritis (RGE) in Oman